No Data
No Data
Ribomic, Stella Pharma, and others.
<3070> Issuance of new shares through Amagasa third-party allocation (6 million shares), issuance of the 4th subscription rights (potential shares of 18 million shares, amount raised of approximately 0.936 billion yen) <4591> Ribomic signs joint research agreement with University of Tokyo on ophthalmic diseases <4888> Stella Pharma, large exercise of the 4th subscription rights (with revision clause for exercise price), delivery of 0.534 million 4000 shares from 12th <9235> Introducing shareholder benefits program for Net Advertisement sales
AMAGASA: Revised Quarterly Report - 35th Quarter 1 (2024/02/01 - 2024/04/30)
AMAGASA: Extraordinary Report
Astroscale Holdings, Amagasa, etc.
<186A> Astroseal Holdings Co., Ltd. Ace Start stock ownership percentage is -% → 5.78%, reporting obligation start date June 5, 2024. <186A> Astroseal Holdings Co., Ltd. INCJ stock ownership percentage is -% → 15.08%, reporting obligation start date June 5, 2024. <186A> Astroseal Holdings Co., Ltd. Mitsunobu Okada stock ownership percentage is -% → 2%.
AMAGASA: Confirmation letter
AMAGASA: Q1 35th Quarterly Report (February 1, 2024 - April 30, 2024)
No Data